Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes

Journal of Molecular and Cellular Cardiology
Delaine K CeholskiRoger J Hajjar

Abstract

Dilated cardiomyopathy (DCM) can be caused by mutations in the cardiac protein phospholamban (PLN). We used CRISPR/Cas9 to insert the R9C PLN mutation at its endogenous locus into a human induced pluripotent stem cell (hiPSC) line from an individual with no cardiovascular disease. R9C PLN hiPSC-CMs display a blunted β-agonist response and defective calcium handling. In 3D human engineered cardiac tissues (hECTs), a blunted lusitropic response to β-adrenergic stimulation was observed with R9C PLN. hiPSC-CMs harboring the R9C PLN mutation showed activation of a hypertrophic phenotype, as evidenced by expression of hypertrophic markers and increased cell size and capacitance of cardiomyocytes. RNA-seq suggests that R9C PLN results in an altered metabolic state and profibrotic signaling, which was confirmed by gene expression analysis and picrosirius staining of R9C PLN hECTs. The expression of several miRNAs involved in fibrosis, hypertrophy, and cardiac metabolism were also perturbed in R9C PLN hiPSC-CMs. This study contributes to better understanding of the pathogenic mechanisms of the hereditary R9C PLN mutation in the context of human cardiomyocytes.

References

Jul 10, 2001·American Journal of Human Genetics·J Schönberger, C E Seidman
Mar 1, 2003·Science·Joachim P SchmittChristine E Seidman
Mar 18, 2003·The Journal of Clinical Investigation·Kobra HaghighiEvangelia G Kranias
Jan 23, 2004·Cardiovascular Research·Marc van BilsenGer J van der Vusse
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Kobra HaghighiEvangelia G Kranias
Apr 1, 2006·Journal of Molecular Biology·Christine B KarimDavid D Thomas
Apr 21, 2007·Nature Protocols·Magdaline CostaEdouard G Stanley
Oct 3, 2007·The Journal of Biological Chemistry·Kim N HaGianluigi Veglia
Mar 3, 2010·Circulation·Eric M SmallEric N Olson
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kim N HaSeth L Robia
Dec 6, 2011·American Heart Journal·Alessandra MedeirosAlexandre C Pereira
Mar 20, 2012·The Journal of Biological Chemistry·Delaine K CeholskiHoward S Young
Apr 17, 2012·Tissue Engineering. Part a·Gregory W SerraoKevin D Costa
Jun 9, 2012·Circulation Research·Evangelia G Kranias, Roger J Hajjar
Jun 19, 2012·The Journal of Biological Chemistry·Delaine K CeholskiHoward S Young
Apr 19, 2013·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·J F van der Heijden, R J Hassink
Aug 1, 2013·Nature Reviews. Cardiology·Ray E HershbergerAna Morales
Dec 11, 2013·Stem Cells Translational Medicine·Ioannis KarakikesRoger J Hajjar
Jun 16, 2014·Nature Methods·Paul W BurridgeJoseph C Wu
Dec 3, 2014·Molecular Therapy. Nucleic Acids·Thomas J CradickGang Bao
Jan 8, 2015·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Howard S YoungCatharine A Trieber
Jan 17, 2015·The Journal of Biological Chemistry·Neha AbrolSeth L Robia
May 31, 2016·JCI Insight·Michael A BurkeChristine E Seidman
Oct 16, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Mark V PintiJohn M Hollander
Nov 22, 2017·Nature Communications·Yassine SassiStefan Engelhardt
Mar 5, 2018·Biochimica Et Biophysica Acta. Biomembranes·Sarah E D NelsonGianluigi Veglia

❮ Previous
Next ❯

Citations

Sep 7, 2019·International Journal of Molecular Sciences·Andreas BrodehlHendrik Milting
Feb 14, 2021·The Journal of Biological Chemistry·Ang LiDavid D Thomas
Apr 4, 2021·Journal of Clinical Medicine·Ilaria My, Elisa Di Pasquale
Dec 17, 2021·Frontiers in Cell and Developmental Biology·Sen LiTingting Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.